DEF 14A: Kinetic Seas Inc. Seeks Stockholder Approval for Past Corporate Actions and Merger
Proxy Statement
Kinetic Seas Incorporated is holding a special meeting of stockholders to ratify past amendments to its Articles of Incorporation and approve actions related to a 2015 merger.
Summary
- Kinetic Seas Incorporated is convening a special meeting of stockholders on May 6, 2024, to address several key corporate matters.
- The primary proposals involve ratifying past amendments to the company's Articles of Incorporation, including name changes, share adjustments, and provisions for shareholder action without a meeting.
- Additionally, stockholders will vote on ratifying and approving actions taken related to a 2015 merger agreement with Oncology Med, Inc. and Oracle Nutraceuticals Company.
- The Board of Directors recommends voting FOR both proposals.
- The record date for determining stockholders eligible to vote is April 4, 2024, with 31,146,000 shares of common stock outstanding as of that date.
- Directors and executive officers control approximately 71.4% of the outstanding voting shares and intend to vote in favor of the proposals.
- The company is providing multiple voting methods, including mail, internet, email, and facsimile, to ensure stockholder participation.
Sentiment
Score: 7
Explanation: The document is factual and procedural, focused on rectifying past corporate actions. The sentiment is neutral to slightly positive as the company is taking steps to address potential legal issues.
Positives
- The ratification of prior corporate acts and the merger closing aims to eliminate potential legal challenges to the company's corporate structure.
- Approval of the proposals may facilitate future capital raising transactions by resolving legal uncertainties.
- The company does not anticipate any material negative consequences from the ratification of these actions.
- The company is providing multiple options for shareholders to vote, including online, by mail, by email and by fax.
Negatives
- Past amendments to the Articles of Incorporation may be invalid due to insufficient stockholder approval.
- The Merger Closing did not occur in the manner provided for in the Merger Agreement.
- Legal uncertainties surrounding the prior corporate acts and merger closing may deter attorneys from issuing opinions needed for capital raising transactions.
Risks
- Failure to ratify the prior corporate acts and merger closing could lead to legal challenges to the company's corporate structure.
- Uncertainties surrounding the validity of past actions may hinder the company's ability to secure legal opinions required for future capital raising transactions.
- The company's reliance on a majority vote from directors and executive officers, who control a significant portion of the voting shares, could limit the influence of other stockholders.
Future Outlook
The company intends to file Amended and Restated Articles of Incorporation if Proposal No. 1 is approved.
Management Comments
- Edward Honour, Chief Executive Officer, cordially invites stockholders to attend the special meeting.
- The Board of Directors recommends that you vote FOR the ratification of the Prior Corporate Acts, and FOR the ratification of the Merger Closing.
Industry Context
This announcement reflects a company addressing potential corporate governance issues to ensure compliance and facilitate future transactions, a common practice among publicly traded companies.
Comparison to Industry Standards
- Ratifying past corporate actions is a standard procedure when discrepancies or insufficient approvals are identified, similar to actions taken by other companies to maintain legal compliance.
- Seeking shareholder approval for significant corporate events like mergers and amendments to articles of incorporation aligns with corporate governance best practices observed across various industries.
- The level of detail provided in the proxy statement is consistent with industry standards for transparency and disclosure to shareholders, comparable to proxy statements issued by companies like Apple, Microsoft, and Google.
Stakeholder Impact
- Shareholders are asked to vote on important corporate matters that could affect the company's legal standing and future transactions.
- Employees may be indirectly affected by the outcome of the vote, as it could impact the company's ability to raise capital and pursue strategic initiatives.
- The outcome of the vote could impact the company's relationships with suppliers and creditors, as it could affect the company's financial stability and legal compliance.
Next Steps
- Stockholders to vote on the proposals at the Special Meeting on May 6, 2024.
- The company will file the Amended and Restated Articles of Incorporation if Proposal No. 1 is approved.
- The company will report the voting results on Form 8-K within four business days after the end of the Special Meeting.
Key Dates
| Date | Description |
|---|---|
| January 3, 2015 | Date of the Agreement of Merger and Plan of Reorganization by and among the Company, Oncology Med, Inc. and Oracle Nutraceuticals Company. |
| January 5, 2015 | Merger Agreement filed with the Secretary of State of Colorado. |
| January 18, 2015 | Amendment to the Articles of Incorporation filed to change the name of the Company to Oncology Med, Inc. |
| January 16, 2015 | Effective date of the Merger Agreement. |
| September 16, 2016 | Amendment to the Articles of Incorporation filed to change the name of the Company to Bellatora, Inc. |
| January 17, 2017 | Amendment to the Articles of Incorporation filed to reduce the number of authorized shares of common stock from 2,000,000,000 shares to 200,000,000 shares. |
| September 12, 2022 | Amended and Restated Articles of Incorporation filed, which in part increased the number of authorized shares of preferred stock from 10,000,000 shares to 50,000,000 shares. |
| May 9, 2023 | Amendment to the Articles of Incorporation to effect a net 1 for 100 reverse split. |
| May 9, 2023 | Amendment to the Articles of Incorporation to clarify the par value of shares of capital stock and to add a provision authorizing the Company to take action by written consent of shareholders. |
| January 19, 2024 | Amendment to the Articles of Incorporation filed to change the name of the Company to Kinetic Seas Incorporated. |
| April 4, 2024 | Record date for determining stockholders eligible to vote at the Special Meeting. |
| April 12, 2024 | Proxy materials first made available to KSI stockholders online. |
| April 12, 2024 | Proxy materials first being mailed to certain stockholders. |
| May 5, 2024 | Voting ends at 11:59 pm cst. |
| May 6, 2024 | Date of the Special Meeting of Stockholders at 10:30 am local time. |
Keywords
Kinetic Seas Incorporated, proxy statement, special meeting, stockholders, ratification, merger closing, corporate acts, articles of incorporation, common stock, preferred stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.